S&P 500
Nasdaq
Dow Jones
NVDA
AAPL
TSLA
MSFT
BTC-USD
15-min delayed
Live
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

Haemonetics Corporation

HAE XNYS
$55.12 +0.75 (+1.38%) ▲ 15-min delayed
Open
$53.66
High
$56.11
Low
$51.00
Volume
1.12M
Market Cap
$2.56B

About Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Sector: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Employees: 3.0K Website →

Key Financials

Period Revenue Net Income EPS
Q3 2026 $338.97M $44.74M $0.96
Q2 2026 $327.31M $38.68M $0.81
Q1 2026 $321.39M $34.03M $0.71
FY 2025 $1.36B $167.68M $3.33

Earnings & Analyst Ratings

Next Earnings: Wed, Aug 5, 2026
Calendar →

Related Market News

No specific coverage for HAE yet. Check out our latest market news or earnings calendar.

Get HAE Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Haemonetics Corporation.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.